The FASEB Journal • Research Communication
Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes O. Kunduzova,*,†,1 N. Alet,‡ N. Delesque-Touchard,‡ L. Millet,‡ I. Castan-Laurell,*,† C. Muller,†,§ C. Dray,*,† P. Schaeffer,‡ J. P. Herault,‡ P. Savi,‡ F. Bono,‡ and P. Valet*,† *Institut National de la Sante´ et de la Recherche Me´dicale (INSERM), U858, Toulouse, France; † Universite´ de Toulouse, Institut de Me´decine Mole´culaire de Rangueil, IFR31, Toulouse, France; ‡ Angiogenesis and Thrombosis Department, Sanofi-Aventis Research, Toulouse, France; and §Institut de Pharmacologie et de Biologie Structurale, CNRS UMR 5089, Toulouse, France Adipose tissue is an active endocrine organ that produces a variety of secretory factors involved in the initiation of angiogenic processes. The bioactive peptide apelin is the endogenous ligand of the G protein-coupled receptor, APJ. Here we investigated the potential role of apelin and its receptor, APJ, in the angiogenic responses of human endothelial cells and the development of a functional vascular network in a model of adipose tissue development in mice. Treatment of human umbilical vein endothelial cells with apelin dose-dependently increased angiogenic responses, including endothelial cell migration, proliferation, and Matrigel® capillary tubelike structure formation. These endothelial effects of apelin were due to activation of APJ, because siRNA directed against APJ, which led to long-lasting down-regulation of APJ mRNA, abolished cell migration induced by apelin in contrast to control nonsilencing siRNA. Hypoxia upregulated the expression of apelin in 3T3F442A adipocytes, and we therefore determined whether apelin could play a role in adipose tissue angiogenesis in vivo. Epididymal white adipose tissue (EWAT) transplantation was performed as a model of adipose tissue angiogenesis. Transplantation led to increased apelin mRNA levels 2 and 5 days after transplantation associated with tissue hypoxia, as evidenced by hydroxyprobe staining on tissue sections. Graft revascularization evolved in parallel, as the first functional vessels in EWAT grafts were observed 2 days after transplantation and a strong angiogenic response was apparent on day 14. This was confirmed by determination of graft hemoglobin levels, which are indicative of functional vascularization and were strongly increased 5 and 14 days after transplantation. The role of apelin in the graft neovascularization was then assessed by local delivery of stable complex apelin-targeting siRNA leading to dramatically reduced apelin mRNA levels and vascularization (quantified by hemogloblin content) in grafted EWAT on day 5 when compared with control siRNA. Taken together, our data provide the first evidence that apelin/APJ signaling pathways play a critical role in the development of the functional vascular network in adipose tissue. In addition, we have
ABSTRACT
4146
shown that adipocyte-derived apelin can be up-regulated by hypoxia. These findings provide novel insights into the complex relationship between adipose tissue and endothelial vascular function and may lead to new therapeutic strategies to modulate angiogenesis.— Kunduzova, O., Alet, N., Delesque-Touchard, N., Millet, L., Castan-Laurell, I., Muller, C., Dray, C., Schaeffer, P., Herault, J. P., Savi, P., Bono, F., Valet, P. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J. 22, 4146 – 4153 (2008) Key Words: apelinergic system 䡠 adipocyte 䡠 neovascularization 䡠 hypoxia 䡠 fat grafting 䡠 angiogenesis White adipose tissue (WAT) has long been viewed primarily as a passive energy storage organ. The discovery of leptin, followed by many other adipocyte-derived factors, identified the tissue as one of the main endocrine organ producing numerous bioactive proteins (adipocytokines) with a broad spectrum of activities, including lipid metabolism, hemostasis, appetite and energy balance, immunity, insulin sensitivity, angiogenesis, inflammation, and blood pressure regulation (1–3). Adipose tissue is able to integrate signals from other organs and respond by regulating secretion of adipokines acting locally and distally through autocrine, paracrine, and endocrine interactions. A number of adipocyte-derived factors, including vascular endothelial growth factor (VEGF), nerve growth factor, leptin, plasminogen activator inhibitior type 1, and tumor necrosis factor-␣, affect vascular endothelial function to drive angiogenesis (4 – 6). Accumulating evidence suggests that hypoxia is the major trigger for the initiation of angiogenesis in most tissues (7, 8). In adipocytes, hypoxia markedly enhances expression and secretion of VEGF and other proangiogenic factors, and it has been suggested that hypoxia might be a 1 Correspondence: INSERM, U858, Toulouse, Cedex 4, France. E-mail:
[email protected] doi: 10.1096/fj.07-104018
0892-6638/08/0022-4146 © FASEB
modulator of the strong angiogenic process associated with adipose tissue expansion (6, 9). Furthermore, Rupnick and colleagues (10) have recently speculated that neovascularization may be critical for adipose tissue growth. They showed that systemic treatment with angiogenesis inhibitors resulted in weight reduction and adipose tissue loss in various mouse models of obesity. However, the precise mechanisms and the mediators involved in the crosstalk between adipocytes and endothelial cells remain poorly understood. We have recently shown that a novel adipocytederived factor, apelin, is up-regulated in mouse and human obesity (11, 12). This bioactive peptide is the endogenous ligand of the G protein-coupled receptor, APJ (13). The apelinergic system has a widespread pattern of distribution in the central nervous system and periphery (14, 15). Apelin has been shown to lower blood pressure (16, 17) and modulate contractility of cardiac tissue and blood vessels (18, 19) and food and water intake and pituitary hormone release (20) and may play a role in osteoblast apoptosis (21). More recently apelinergic system has been found to promote embryonic and tumor angiogenesis (22). Considering its production in adipocytes, rise in obesity, and potential effects on angiogenesis, apelin would be a good candidate mediator of the interaction of adipocytes and endothelial cells leading to increased angiogenesis during adipose tissue expansion in obesity. The aim of the present study therefore was to determine whether apelin might play a role in adipose tissue angiogenesis. Therefore, the effect of hypoxia on apelin production in adipocytes and the effect of the apelin/APJ signaling on endothelial cell responses were assessed in vitro. Furthermore, apelin production during adipose tissue hypoxia and the effect of apelin down-regulation were determined in an in vivo model of adipose tissue-induced angiogensis after adipose tissue transplantation.
MATERIALS AND METHODS Cell culture Human umbilical vein endothelial cells (HUVECs; Clonetics, Walkersville, IL, USA) were cultured in endothelial cell growth medium-2 (Clonetics). Cells between passages 3 and 8 were used in these studies. The mouse preadipose cell line 3T3F442A was grown at 37°C in 5% CO2 in Dulbecco modified Eagle medium (DMEM) containing 25 mM glucose, 100 U/ml penicillin, 100 g/ml streptomycin (culture medium), and 10% donor calf serum. For differentiation, confluent preadipocytes were cultured in culture medium supplemented with 10% fetal calf serum and 50 nM insulin for 8 –10 days, after which more than 90% of the cells had accumulated fat droplets. Total RNAs were prepared at different time points after induction of the differentiation using the RNeasy mini kit (Qiagen, Valencia, CA, USA). For hypoxia studies, 3T3F442A adipocytes were cultivated as described previously (11) up to day 10 of differentiation. Cells were maintained in a hypoxia chamber (In vivo2 400; Ruskinn Inc., Cincinnati, OH, USA) for 8, 24, or 48 h in APELIN/APJ SIGNALING SYSTEM
comparison with normoxia conditions. In this study normoxia was considered as the ambient atmosphere containing 21% O2 and hypoxia, 1% O2. Proliferation assay To determine cell proliferation, HUVECs were seeded in 96-well plates (5 wells/condition) and incubated with basic fibroblast growth factor (bFGF; 3 nM; Life Technologies, Inc., Gaithersburg, MD, USA) or apelin-13 (20, 60, 200, or 600 nM; 2, 6, 20, or 60 M; Bachem, Torrance, CA, USA; H-4566), after serum starvation. The media and factors were replaced twice during experiments. On day 7 after starting proliferation, viable cells were counted using the CellTiter-Glo Luminescent Cell Viability Assay (Promega Corp., Madison, WI, USA). Migration assay Endothelial cell migration was evaluated in a modified Boyden chamber assay as described previously (23). Briefly, HUVECs were detached with trypsin, counted, centrifuged, and resuspended in DMEM serum-free medium. Cells (5⫻104) were plated on the upper chamber. In the lower chamber of the Boyden apparatus, human recombinant bFGF (6 nM, Life Technologies) or apelin-13 (2, 6, 20, 60 M) were used as chemoattractants. After incubation at 37°C for 22 h, cells were labeled with calcein AM (Molecular Probes, Eugene, OR, USA) according to the manufacturer’s instructions. Fluorescence of cells that had migrated was measured on a Tecan GENios microplate reader (Tecan, Ma¨nnedorf, Switzerland). All the experiments were carried out at least 3 times in duplicate. In vitro angiogenesis assay Growth factor-reduced Matrigel (BD Biosciences, San Jose, CA, USA) was diluted in collagen (1:6 v/v) and kept on ice. This solution (160 l) was added to each well of 8-well culture slides precoated with type 1 rat tail collagen and left at 37°C for 1 h. An HUVEC suspension, untreated or treated with bFGF (3 nM) or apelin-13 (60 nM, 200 nM, 600 nM, 2 M, 6 M), was seeded into the Matrigel/collagen gel for 24 h at 37°C. Microtubules were quantified by microscopy, as described previously (24). Briefly, the culture medium was removed, and cells were rinsed twice with PBS and fixed for 30 min at room temperature in a 4% paraformaldehyde solution. Then the cells were washed twice with PBS and stained with Masson trichrome. The formation of the capillary/tubelike networks were examined using a Nikon Eclipse TE-2000 E microscope (⫻4) equipped with a DXM1200 digital camera (Nikon, Champigny sur Marne, France). Microcapillary network was manually drawn with a pointing device, and the total length of all the capillary tubes in each well was measured using Morpho Expert Image Analysis software (Biocom, Les Ulis, France). All experiments were performed in triplicate and repeated 3 times. HUVEC transfection with siRNA duplexes The Stealth Select RNAi for APJ and Stealth RNAi Negative Control were obtained from Invitrogen (Carlsbad, CA, USA). The siRNA sequence targeting human APJ corresponded to the coding region 184 –208 relative to the first nucleotide of the start codon (NM_005161.3). Preliminary transient transfection of HUVECs was carried out to test APJ siRNA efficiency. HUVECs were trypsinized, washed with HBSS, and 4147
resuspended (1⫻106 cells) in HUVEC solution (Amaxa Biosystems, Gaithersburg, MD, USA) containing 1 nM siRNA duplex and were transfected using a Nucleoporator (Amaxa Biosystems) following the manufacturer’s instructions. After transfection, cells were immediately seeded into 12-well plates containing complete media. We evaluated siRNA activity by determining APJ mRNA level 6, 24, and 48 h later. For migration assay, 24 h after transfection HUVECs (5⫻104) were detached with trypsin, counted, centrifuged, and resuspended in DMEM serum-free medium. This assay provides a simple, convenient method to determine the functional consequences of APJ pathway. Apelin at the dose of 50 g/ml was used as chemoattractant as described below. Quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR) In 3T3F442A adipocytes, the total RNAs (1 g) were reverse transcribed using random hexamers and Superscript II reverse transcriptase (RT; Invitrogen). The same reaction was performed without Superscript II (RT–) to estimate DNA contamination. The range of cycle threshold (Ct) values for Ct gene was 23–26, whereas Ct RT– was 35, meaning that very little (⬍0.1%) of genomic DNA is present in our samples. Real-time PCR was performed starting with 12.5 ng cDNA and both sense and antisense oligonucleotides in a final volume of 25 l using the SYBR green TaqMan universal PCR master mix (Applied Biosystems, Warrington, UK). Fluorescence was monitored and analyzed in a GeneAmp 7000 detection system instrument (Applied Biosystems). Analysis of the 18S rRNA was performed in parallel using the rRNA control Taqman assay kit (Applied Biosystems) to normalize gene expression. Oligonucleotide primers were designed using the Primer Express software (Applied Biosystems). All primers used were validated for PCR efficiency. Human APJ and murine apelin were analyzed by reverse transcription and real-time PCR by using RNA samples from transfected cells or siRNA-injected WAT graft. PCR reactions were carried out using Assays-on-DemandTM Gene Expression Products (PE Applied Biosystems, Weiterstadt, Germany). Reactions were performed as described previously (25). The calculations of the initial mRNA copy numbers in each sample were made according to the cycle threshold method (26) and normalized using TATA binding protein mRNA levels. Animals All experiments were performed in accordance with the recommendations of the French Accreditation of the Laboratory Animal Care and were approved by the local Centre National de la Recherche Scientifique ethics committee. In the current study we used 7-wk-old male C57BL6/J mice purchased from Charles River Laboratories (l’Arbresle, France). Donor and recipient mice were age-matched to minimize rejection. The recipients were anesthetized with an anesthesia cocktail composed of 5 mg/kg xylazine and 50 mg/kg ketamine. Donor mice were killed by cervical dislocation. Implantation was performed with aseptic techniques. After shaving the hair on the dorsal side, 1 subcutaneous air pocket in the inguinal region was prepared, and whole pieces of epididymal WAT (EWAT; 600 mg) from 2 donors were inserted into the air pocket of the recipient through a 1 cm midline incision. Incisions were closed with sterile surgical staples. All animals were housed individually for the duration of the experiment. At various times after implantation, grafted WATs were photographed, half of each EWAT was cut into small pieces and stored at – 80°C for RNA isolation, or 4148
Vol. 22
December 2008
used for evaluation of EWAT graft vascularization. Normal EWAT was employed as a control. For histological examination, EWAT was fixed in Znformalin for 24 h and then embedded in paraffin for subsequent trichrome staining of 10 m thickness sections. In vivo delivery of siRNA/apelin In this research we make use of siRNA to silence apelin within adipose tissue. First, in vitro studies are conducted for developing siRNA carrier/delivery technique. Those are then followed by in vivo studies to optimize the technique for siRNA delivery. The siRNA duplex targeting murine apelin was commercially obtained from Ambion, Inc. (Austin, TX, USA; ID 184196). For local delivery, siRNA (10 g/10 l per graft) was diluted in PBS and delivered locally. The single injection was given by a 32-gauge Hamilton syringe (Hamilton Co., Reno, NV, USA) just before implantation. Quantification of angiogenesis by hemoglobin (Hb) measurement The extent of the vascularization of the EWAT grafts was assessed by the amount of Hb detected in the tissue using the Drabkin method (27). Each implant was homogenized (TR10; Tekmar, Mason, OH, USA) in 2.0 ml of Drabkin reagent (Labtest, Sa˜o Paulo, Brazil) and centrifuged at 10,000 g for 15 min. The supernatants were filtered through a 0.22 m filter (Millipore Co., Bedford, MA, USA). Hb in the samples was determined spectrophotometrically by measuring absorbance at 540 nm using an ELISA plate reader and compared against a standard curve of Hb. The content of Hb in the granulation tissue was expressed as g Hb per g wet tissue. Tissue hypoxia Pimonidazole hydrochloride (Hypoxyprobe-1; Chemicon International Inc., Temucula, CA, USA) was injected intraperitoneally into mice (200 mg/kg). One hour after injection, adipose tissue was dissected, fixed in formalin, and embedded in paraffin. Sections were cut at 10 m thickness, and tissue hypoxia was detected by Hypoxyprobe-1 and horseradish peroxidase-conjugated F(ab⬘)2 fragment of anti-mouse immunoglobulin G (IgG) antibody. Brown color was generated using diaminobenzidine as substrate. Control experiments were performed by injecting saline in place of Hypoxyprobe-1, and WAT sections were labeled exactly as described above. Statistical analysis Data are expressed as means ⫾ se. Statistical analyses were performed by 1-way ANOVA followed by the Bonferroni t test. Values of P ⬍ 0.05 were considered statistically significant.
RESULTS Up-regulation of apelin expression by hypoxia in 3T3F442A adipocytes To determine the effect of hypoxia on apelin mRNA expression in adipocytes, differentiated 3T3F442A cells were subjected to hypoxia (1% O2) for 8, 24, and 48 h. Figure 1 shows that vs. time-matched normoxic control cells, hypoxia increased both apelin and VEGF mRNA
The FASEB Journal
KUNDUZOVA ET AL.
migration (Fig. 2B) and Matrigel capillary/tubelike structure formation (Fig. 2C). To determine the functional consequences of the APJ pathway, we assessed the specific silencing effect of siRNA/APJ on the endothelial cell migration. To address this question, HUVECs were first transfected with either negative control siRNA or APJ/siRNA. Twentyfour and 48 h following siRNA transfection, RNAs were
Figure 1. Effect of hypoxia on apelin and VEGF mRNA expression in 3T3F442A adipocytes. Differentiated (day 10) 3T3F442A adipocytes were subjected to hypoxia (1% O2) for 8, 24, and 48 h or in parallel were grown under normoxia as a control. Values normalized to 18S rRNA levels are given as means ⫾ se from 3 separate experiments. ***P ⬍ 0.001 vs. control.
expression in a time-dependent manner. Exposure of 3T3F442A to hypoxia caused a rapid increase in apelin mRNA with a peak induction (17-fold) at 8 h. The apelin mRNA remained elevated above the control (normoxia) level for the entire exposure to hypoxia (48 h). At the same time, VEGF mRNA expression significantly increased by 4-fold at 8 h and reached a peak value (7-fold) at 48 h of hypoxia. Apelin-induced angiogenic responses on HUVECs The formation of microvessels involves the coordinated proliferation, migration, and morphogenetic organization of endothelial cells into capillary tubes. We further examined the effects of apelin on HUVEC proliferation, migration, and angiogenesis. The cellular responses of HUVECs to apelin treatment were compared to those of bFGF. As shown in Fig. 2A, the treatment of HUVECs with apelin significantly increased cell proliferation in a dose-dependent manner up to100 g/ml of apelin (Fig. 1A). In addition, apelin at high doses also induced a significant increase in endothelial cell APELIN/APJ SIGNALING SYSTEM
Figure 2. Dose-dependent effect of apelin on HUVEC proliferation (A), migration (B), and angiogenesis (C). A) Cells were treated with various concentrations of apelin (20 nM– 60 M) or bFGF (3 nM) after serum starvation. After 7 days, viable cells were counted using the CellTiter-Glo Luminescent Cell Viability Assay. Values are means ⫾ se from 5 wells; graph is a representative result from triplicate experiments. B) Cells were treated with mitogens for 22 h, then migration was measured using modified Boyden chamber assay. Experiments were carried out at least 3 times in triplicate. C) Top panel shows representative photographs of the tube formation induced by apelin at 24 h after HUVEC treatment. Average tube length was obtained by measuring as described in Materials and Methods and is expressed as the mean ⫾ se from 3 independent experiments (bottom panel). *P ⬍ 0.05, **P ⬍ 0.01 vs. control. 4149
prepared to examine APJ expression using real-time PCR analysis. In cells transfected with negative control siRNA, APJ expression was not diminished. By contrast, APJ mRNA was significantly reduced after 24 and 48 h of APJ siRNA transfection in HUVECs (Fig. 3A). As shown in Fig. 3B, siRNA-mediated down-regulation of APJ in HUVECs specifically and significantly reduced cell migration induced by apelin as compared with the control nonsilencing siRNA. Apelin-dependent angiogenesis in adipose tissue Although angiogenesis appears to be linked to the activity of adipose tissue-derived proangiogenic factors,
Figure 3. Apelin effect on HUVEC migration after 48 h of siRNA/APJ transfection. A) For evaluation of siRNA efficiency and specificity, HUVECs were first transcfected with either negative control siRNA or APJ:/siRNA. At 24 and 48 h after siRNA transfection, RNAs were prepared to examine APJ expression using real-time PCR analysis. B) The specific silencing effect of APJ/siRNA was evaluated on the endothelial cell migration model. HUVECs were transfected using Amaxa nucleofection technology. After transfection (24 h), cells were treated for 22 h with 20 M apelin (A) or without apelin (C), then migration was measured using modified Boyden chamber assay. Experiments were carried out at least 3 times in triplicate. **P ⬍ 0.01, ***P ⬍ 0.001 vs. control. 4150
Vol. 22
December 2008
very little is known about angiogenesis in adipose tissue, primarily because of the absence of reliable in vivo model. To address this question, we have set up a murine model allowing reliable and quantitative assessment of local adipose tissue-related angiogenesis that involves EWAT implantation. The surgical implantation of EWAT (600 mg) into mice was well tolerated by all animals. No sign of infection or rejection was observed in the implant compartment during the 14 day period of the experiment. As shown in Fig. 4A, the formation of new blood vessels in EWAT grafts was already observed on day 2. In contrast to control (EWAT on day 0), the grafted EWAT shows a welldeveloped vasculature on day 14. The development of a vascular supply within adipose tissue was associated with a concomitant and significant elevation in Hb content (Fig. 4B) and VEGF-R2 level (Fig. 4C) in grafted EWAT on days 5 and 14. In this active phase of adipose tissue-derived angiogenesis, we found high apelin mRNA expression in EWAT grafts (Fig. 4D). In addition, the functional neovascularization of adipose tissue was also confirmed by histological analysis of EWAT grafts (Fig. 5A). Light microscopic examination of WAT sections revealed an enhanced collagen deposition (blue) and a numerous blood vessels (red) in EWAT grafts on days 5 and 14 compared with control (EWAT on day 0). As shown by our in vitro experiments, hypoxia induced a time-dependent increase in apelin of differentiated 3T3F442A. We next studied the tissue hypoxia during neovascularization of grafted EWAT on days 0, 2, 5, and 14 using pimonidazole hydrochloride, which forms protein adducts in tissue that experience an oxygen level of ⬃1% O2. Pimonidazole staining revealed that peripheral regions of EWAT experienced a discrepancy between oxygen supply and demand as early as 2 days after transplantation (Fig. 5B), which was sustained throughout the early phase of angiogenesis in the grafted EWAT (day 5). In contrast, no hypoxia was observed in grafted EWAT on day 14. To elucidate the role of apelinergic system in WATderived angiogenesis, we down-regulated apelin using siRNA-mediated gene silencing in WAT grafts. In the murine model of adipose tissue derived angiogenesis, we found that local intragraft administration of stable complex apelin-targeting siRNA (50M, 40 l), but not of control siRNA, led to the significant decrease in Hb content (36% vs. control) of WAT grafts in the active phase of adipose tissue neovascularization (Fig. 6A, B). As shown in Fig. 6C, this effect was correlated with a down-regulation (52% vs. control) of apelin mRNA expression.
DISCUSSION The present study discloses a potential link between adipose tissue and active angiogenic processes through apelin/APJ signaling. Here we provide novel evidence for the critical role of the apelinergic system in the
The FASEB Journal
KUNDUZOVA ET AL.
A
B
C
D
Figure 4. Kinetics of apelin-dependent adipose tissue-derived angiogenesis on the mouse model. A) Representative photos show the development of adipose tissue-derived angiogenesis: a) adipose tissue before EWAT implantation (day 0), b) appearance of new blood vessels in grafted EWAT on day 2, c) active-developed vasculature of EWAT grafts on day 5, d) strong-developed vasculature in grafted EWAT on day 14. B) Time course of angiogenesis by Hb measurement in the EWAT grafts. C) Level of VEGF-R2 in EWAT grafts on days 0, 2, 5 and 14. D) Apelin levels in EWAT grafts on days 0, 2, 5 and 14.
regulation of human endothelial cell functions and development of the functional vascular network within adipose tissue. This is the first reported demonstration that hypoxia up-regulates the expression of adipocytederived apelin, which may have important functional consequences for the specific interactions between adipose tissue and endothelial cells in the control of angiogenesis. These findings provide novel insights into the complex relationship between adipose tissue and edothelial angiogenic responses and may lead to new therapeutic strategies to modulate angiogenesis.
Angiogenesis is a multistep process that involves several interrelated reactions, such as endothelial cell migration, proliferation, and capillary tube formation. These processes are tightly regulated by actions of proangiogenic factors such as VEGF, bFGF, and other adipocyte-produced proteins (28, 29). We have previously shown that both human and mouse adipocytes secrete apelin, a newly identified adipokine, associated with obesity-associated metabolic abnormalities (11). In the vascular system apelin and APJ are known to be expressed in endothelium and smooth muscle cells, but
Figure 5. Visualization of adipose tissue hypoxia (A) and neovasculature in adipose tissue grafts after 5 and 14 days posttransplantation. A) Functional neovasculature in adipose tissue grafts. Representative histological sections from paraffinembedded WAT were stained with Masson’s trichrome. Light microscopic examination of WAT sections revealed an enhanced collagen deposition (arrows) and numerous blood vessels (arrowheads) in WAT grafts on days 5 and 14 compared with control (EWAT on day 0) B) Visualization of tissue hypoxia during neovascularization of grafted adipose tissue. Hypoxic areas (brown) were visualized in EWAT of pimonidazole-treated mice (200 mg/kg, i.p.) on days 2 and 5 using the hypoxyprobe-1 monoclonal antibody. Scale bars ⫽ 50 m (A); 250 m (B). APELIN/APJ SIGNALING SYSTEM
4151
Figure 6. Efficiency of siRNA/apelin in a murine model of adipose tissue-derived angiogenesis. A) Representative photos show the dose-dependent effect of siRNA/apelin treatment in WAT-derived angiogenesis on day 5 postimplantation. Stable complex apelin-targeting siRNA (100 M, 40 l) (right panel) or nonsilencing control siRNA (left panel) was locally delivered intragraft just before implantation of WAT into the mice. B) Evaluation of angiogenesis in WAT grafts after treatment with stable siRNA/apelin on day 5. C) Expression of apelin mRNA in WAT grafts on day 5 by real-time PCR.
the biological activity of apelinergic system in the human endothelial cell functions remain to be explored. Kasai et al. (30) have previously reported that apelin stimulates proliferation and migration of RF/6A cells, a rhesus macaque choroid-retina-derived endothelial cells. In our study we demonstrate that apelin is able to induce a proangiogenic response in human endothelial cells. This response includes apelin-dependant stimulation of HUVEC cell migration, proliferation, and matrigel tube formation. Moreover, by using the siRNA approach we have demonstrated that knocking down APJ inhibited apelin-induced HUVEC migration, suggesting a role of the APJ pathway in the functional activity of apelin in the human endothelial cells. In line with our observation, Kalin et al. (22) recently reported that apelin-APJ signaling is essential for embryonic and tumor angiogenesis. However, the mechanisms by which the apelinergic system promotes physiological and pathological angiogenic processes remain to be clarified. Hypoxia is a major driving force for angiogenesis. Hypoxic conditions induce increased transcription of the mRNA for VEGF, leptin, and other proangiogenic factors in adipocytes (6, 9). It is also known that mature adipocytes are capable of enhanced production and release of the critical angiogenic signals under hypoxic conditions (31). In this study, we have examined the adipocyte-specific expression profile of apelin in response to hypoxia. We show that hypoxia up-regulates apelin expression in 3T3F442A adipocytes, suggesting that hypoxia may be a potent regulatory mechanism of activation of the apelinergic system in adipose tissue. Our observations are consistent with a recently reported study (32) that showed that the apelin gene is regulated by hypoxia in adipocytes via the HIF pathway. Several lines of evidence suggest a link between blood vessel formation and adipogenesis (33). During fetal development, arteriolar differentiation precedes adipocyte development, and differentiation of blood vessel extracellular matrix (ECM) precedes differentiation of adipocyte ECM (34). During postnatal development, VEGF expression and resulting angiogenesis may augment adipogenesis in adipose tissue (29). Recently 4152
Vol. 22
December 2008
Rupnick et al. (10) have shown that treatment of mice from different obesity models with angiogenic inhibitors decreased body weight, suggesting that adipose tissue accretion can be regulated through the vasculature. In agreement with this concept, using an in vivo model of adipose tissue-derived angiogenesis, we have demonstrated that adipose tissue is one of the active sites of angiogenic processes. In this model system the first appearance of the newly formed blood vessels around the transplanted adipose tissue was observed on days 2 and 5, indicating that angiogenesis in adipose tissue is a dynamic process characterized by the rapid development of the vascular network. Consistent with our in vitro results in adipocytes, we observed tissue hypoxia and up-regulated apelin expression during the early phase (days 2 and 5) of angiogenic processes in adipose tissue. Our data support the idea that local adipose tissue hypoxia may lead to the stimulation of the production and release of proangiogenic factors, the function of which is to sustain adequate blood flow in the expanding adipose tissue. The hypoxiadependent adipokine dysregulation may be partly responsible for the development of diseases linked to obesity, particularly type II diabetes and the metabolic syndrome. Using siRNA technology, we provide a strong evidence that apelin signaling pathway plays a critical role in the agiogenic activity of adipose tissue. We show that local intragraft administration of stable complex apelintargeting siRNA led to the significant inhibition of active angiogenesis in the grafted adipose tissue. Thus, although APJ levels are relatively low in endothelial cells, such data clearly show that the apelin/APJ complex is responsible of the cellular effect observed. These findings, coupled with the recent demonstration of the involvement of apelin/APJ pathways in microvascular proliferations of brain tumors (22) support the novel notion that the apelinergic system could play an important role in the pathological angiogenesis. Further delineation of the specific upstream molecular pathways through which the apelin/APJ control physiological and pathological angiogenesis is needed. Taken together, our data provide the first evidence that apelin/APJ signaling pathways play a critical role in the development of the functional vascular network in
The FASEB Journal
KUNDUZOVA ET AL.
adipose tissue. In addition, we have shown that adipocyte-derived apelin can be up-regulated by hypoxia. These findings highlight a potential of apelinergic system as a target for developing novel therapeutic strategies to modulate angiogenesis.
18.
We thank Laurence Cazales, Joe¨l Tuyaret, Danie`le Daviaud, Isabelle Senegas, and Patrice Rigon for their efficient technical help.
19.
REFERENCES 1. 2. 3. 4.
5. 6. 7. 8. 9.
10.
11.
12.
13.
14.
15.
16.
Trayhurn, P., and Beattie, J. H. (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60, 329 –339 Rosen, E. D., and Spiegelman, B. M. (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847– 853 Ahima, R. S. (2006) Adipose tissue as an endocrine organ. Obesity 14, 242S–249S Sierra-Honigmann, M. R., Nath, A. K., Murakami, C., GarciaCardena, G., Papapetropoulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini P. J., and FloresRiveros, J. R. (1998) Biological action of leptin as an angiogenic factor. Science 281, 1683–1686 Papetti, M., and Herman, I. M. (2002) Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282, C947–C970 Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature 14, 242–248 Hickey, M. M., and Simon, M. C. (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr. Top. Dev. Biol. 76, 217–257 Hirota, K., and Semenza, G. L. (2006) Regulation of angiogenesis by hypoxia-inducible factor 1. Crit. Rev. Oncol. Hematol. 59, 15–26 Lolmede, K., Durand de Saint Front, V., Galitzky, J., Lafontan, M., and Bouloumie, A. (2003) Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3– F442A adipocytes. Int. J. Obes. Relat. Metab. Disord. 27, 1187–1195 Rupnick, M. A., Panigrahy, D., Zhang, C. Y., Dallabrida, S. M., Lowell, B. B., Langer, R., and Folkman, M. J. (2002) Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. U. S. A. 99, 10730 –10735 Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigne, C., Mazzucotelli, A., Castan-Laurell, I., Tack, I., Knibiehler, B., Carpene, C., Audigier, Y., Saulnier-Blache, J. S., and Valet, P. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146, 1764 –1771 Daviaud, D., Boucher, J., Gesta, S., Dray, C., Guigne, C., Quilliot, D., Ayav, A., Ziegler, O., Carpene, C., Saulnier-Blache, J. S., Valet, P., and Castan-Laurell, I. (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 20, 1528 –1530 Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M. X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., Kurokawa, T., Onda, H., and Fujino, M. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251, 471– 476 Hosoya, M., Kawamata, Y., Fukusumi, S., Fujii, R., Habata, Y., Hinuma, S., Kitada, C., Honda, S., Kurokawa, T., Onda, H., Nishimura, O., and Fujino, M. (2000) Molecular and functional characteristics of APJ: tissue distribution of mRNA and interaction with the endogenous ligand apelin. J. Biol. Chem. 275, 21061–21067 O’Carroll, A. M., Selby, T. L., Palkovits, M., and Lolait, S. J. (2000) Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim. Biophys. Acta 1492, 72– 80 Tatemoto, K., Takayama, K., Zou, M. X., Kumaki, I., Zhang, W., Kumano, K., and Fujimiya, M. (2001) The novel peptide apelin
APELIN/APJ SIGNALING SYSTEM
17.
20.
21. 22.
23.
24.
25.
26. 27. 28. 29. 30.
31.
32.
33.
34.
lowers blood pressure via a nitric oxide-dependent mechanism. Regul. Pept. 99, 87–92 Cheng, X., Cheng, X. S., and Pang, C. C. (2003) Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur. J. Pharmacol. 470, 171–175 Szokodi, I., Tavi, P., Foldes, G., Voutilainen-Myllyla, S., Ilves, M., Tokola, H., Pikkarainen, S., Piuhola, J., Rysa, J., Toth, M., and Ruskoaho, H. (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ. Res. 91, 434 – 440 Farkasfalvi, K., Stagg, M. A., Coppen, S. R., Siedlecka, U., Lee, J., Soppa, G. K., Marczin, N., Szokodi, I., Yacoub, M. H., and Terracciano, C. M. (2007) Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem. Biophys. Res. Commun. 357, 889 – 895 Taheri, S., Murphy, K., Cohen, M., Sujkovic, E., Kennedy, A., Dhillo, W., Dakin, C., Sajedi, A., Ghatei, M., and Bloom, S. (2002) The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem. Biophys. Res. Commun. 291, 1208 –1212 Xie, H., Yuan, L. Q., Luo, X. H., Huang, J., Cui, R. R., Guo, L. J., Zhou, H. D., Wu, X. P., and Liao, E. Y. (2007) Apelin suppresses apoptosis of human osteoblasts. Apoptosis 12, 247–254 Kalin, R. E., Kretz, M. P., Meyer, A. M., Kispert, A., Heppner, F. L., and Brandli, A. W. (2007) Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev. Biol. 305, 599 – 614 Favier, B., Alam, A., Barron, P., Bonnin, J., Laboudie, P., Fons, P., Mandron, M., Herault, J. P., Neufeld, G., Savi, P., Herbert, J. M., and Bono, F. (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108, 1243–1250 Ruggeri, B., Singh, J., and Gingrich, D. (2003) CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Cancer Res. 63, 5978 –5991 Fons, P., Herault, J. P., Delesque, N., Tuyaret, J., Bono, F., and Herbert, J. M. (2004) VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells. J. Cell. Physiol. 200, 351–359 Higuchi, R., Fockler, C., Dollinger, G., and Watson, R. (1993) Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Bio/Technology (N. Y.) 11, 1026 –1030 Drabkin, D. L., and Austin, J. H. (1932) Spectrophotometric constants common hemoglobin derivatives in human, dog, and rabbit blood. J. Biol. Chem. 98, 719 –733 Suhardja, A., and Hoffman, H. (2003) Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc. Res. Tech. 60, 70 –75 Hausman, G. J., and Richardson, R. L. (2004) Adipose tissue angiogenesis. J. Anim. Sci. 82, 925–934 Kasai, A., Shintani, N., Oda, M., Kakuda, M., Hashimoto, H., Matsuda, T., Hinuma, S., and Baba, A. (2004) Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem. Biophys. Res. Commun. 325, 395– 400 Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., TemmGrove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., and March, K. L. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292–1298 Glassford, A. J., Yue, P., Sheikh, A., Chun, H. J., Zarafshar, S. Y., Chan, D. A., Reaven, G. M., Quertermous, T., and Tsao, P. S. (2007) HIF-1-mediated regulation of hypoxia- and insulin-induced expression of apelin in adipocytes. Am. J. Physiol. Endocrinol. Metab. 293, E1590 –E1596 Fukumura, D., Ushiyama, A., Duda, D. G., Xu, L., Tam, J., Krishna, V., Chatterjee, K., Garkavtsev, I., and Jain, R. K. (2003) Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ. Res. 93, e88 – e97 Crandall, D. L., Hausman, G. J., and Kral, J. G. (1997) A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4, 211–232 Received for publication January 18, 2008. Accepted for publication July 17, 2008.
4153
